#Weltdiabetestag: Insulin icodec ist neu, aber auch besser? Die Arzneimittelkommission der deutschen Ärzteschaft sieht wegen der häufigeren Unterzuckerungen bei Typ-1-#Diabetes sogar Anhaltspunkte für einen geringeren Nutzen von #Insulin #icodec. (€)
New—Once‑weekly #IcoSema versus once‑weekly #insulin #icodec in type 2 #diabetes management (COMBINE 1): an open‑label, multicentre, treat‑to‑target, randomised, phase 3a trial thelancet.com/journals/lan... #T2D
#MedSky #EndoSky
A combination of #insulin #icodec and #semaglutide, led to superior reduction in HbA1c after 52 wks vs once-weekly #semaglutide in the #COMBINE_2 study #DiabetesResearch #Endocrinology #MedSky
In adults with #T2D in #COMBINE_2, #once-weekly #IcoSema, a combination of #icodec and #semaglutide, led to superior reduction in HbA1c after 52 wks vs once-weekly #semaglutide, with similar #hypoglycaemia rates, but weight change favoured semaglutide tinyurl.com/b3uwndny 🔓
Should everyone switch from once-daily insulins to #icodec or #efsitora?
#EASD Board Member Julia Mader lets you know who would benefit from once-weekly #insulins, discussing the latest data (#QWINT2) in this Expert Insights ep.
🎥👉https://easd-elearning.eu/Expert_Insights_14.html
#diabetes